{"id":51530,"date":"2021-08-05T10:13:22","date_gmt":"2021-08-05T14:13:22","guid":{"rendered":"https:\/\/regstaging.wpengine.com\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/"},"modified":"2021-08-19T09:50:19","modified_gmt":"2021-08-19T13:50:19","slug":"fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022","status":"publish","type":"post","link":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/","title":{"rendered":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022"},"content":{"rendered":"

A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos Estados Unidos (FDA) anunciou novas taxas para o ano fiscal (FY) 2022 sob a altera\u00e7\u00e3o das taxas de usu\u00e1rios para medicamentos gen\u00e9ricos (GDUFA) e a altera\u00e7\u00e3o da taxa de usu\u00e1rio para dispositivos m\u00e9dicos (MDFA).<\/p>\n

O ano fiscal come\u00e7a em 1\u00ba de outubro de 2021 e termina em 30 de setembro de 2022. Os estabelecimentos de medicamentos e dispositivos m\u00e9dicos devem pagar as taxas para manter seu status de acordo com a FDA.<\/p>\n

Taxas para Estabelecimentos de Medicamentos<\/strong><\/p>\n

Sob a Lei GDUFA, a FDA avalia e coleta as taxas de estabelecimentos de ingredientes farmac\u00eauticos ativos (API), estabelecimentos de f\u00f3rmulas de dosagem finais (FDF) e organiza\u00e7\u00e3o contratada para fabrica\u00e7\u00e3o (CMO). As taxas dos estabelecimentos fora dos Estados Unidos s\u00e3o maiores para compensar o custo adicional de uma inspe\u00e7\u00e3o.<\/p>\n

As taxas GDUFA de estabelecimento aumentaram para o ano fiscal 2022, revertendo a redu\u00e7\u00e3o da taxa de 2020 a 2021. As taxas de API nacionais e estrangeiras aumentaram em aproximadamente 2%. As taxas de FDF e CMO aumentaram tanto para empresas dos EUA. Quanto \u00e0s empresas estrangeiras em aproximadamente 5%. Pelo contr\u00e1rio, as empresas de todos os tamanhos viram aproximadamente uma redu\u00e7\u00e3o de 0,4% nas taxas de programas.<\/p>\n

O aumento das taxas dos estabelecimentos poder\u00e1 ter um ajuste do ano passado, o que permite ao FDA aumentar as taxas para fornecer at\u00e9 3 meses de reservas operacionais. As reservas compensar\u00e3o os custos associados \u00e0s atividades de medicamentos gen\u00e9ricos humanos projetadas para o in\u00edcio do ano fiscal 2023. Para determinar o ajuste, a FDA analisou a coleta e obriga\u00e7\u00f5es projetadas considerando que o encargo financeiro aumentou as taxas no setor. Em \u00faltima an\u00e1lise, a FDA decidiu aumentar as taxas para fornecer 7 semanas de reservas operacionais.<\/p>\n

Taxas de GDUFA Para Ano Fiscal<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Tipo de Taxa<\/strong><\/td>\nFY 2021<\/strong><\/td>\nFY 2022<\/strong><\/td>\n<\/tr>\n
Taxas de Estabelecimentos<\/strong><\/td>\nDom\u00e9stico<\/strong><\/td>\nEstrangeiro<\/strong><\/td>\nDom\u00e9stico<\/strong><\/td>\nEstrangeiro<\/strong><\/td>\n<\/tr>\n
Ingrediente Farmac\u00eauticos Ativos (API)<\/td>\nU$ 41,671<\/td>\nU$ 56,671<\/td>\nU$ 42,557<\/td>\nU$ 57,557<\/td>\n<\/tr>\n
Forma de Dosagem finais (FDF)<\/td>\nU$ 184,022<\/td>\nU$ 199,022<\/td>\nU$ 195,012<\/td>\nU$ 210,012<\/td>\n<\/tr>\n
Organiza\u00e7\u00e3o de Fabricantes por Contrato (CMO)<\/td>\nU$ 61,341<\/td>\nU$ 76,341<\/td>\nU$ 65,004<\/td>\nU$ 80,004<\/td>\n<\/tr>\n
Taxas do Programa GDUFA: Com Base no N\u00famero de ANDAs aprovadas<\/strong><\/td>\n<\/tr>\n
Grande (20 ou mais ANDAs)<\/td>\nU$ 1,542,993<\/td>\nU$ 1,536,856<\/td>\n<\/tr>\n
M\u00e9dio (6 a 19 ANDAs)<\/td>\nU$ 617,197<\/td>\nU$ 614,742<\/td>\n<\/tr>\n
Pequeno (5 ou menos ANDAs)<\/td>\nU$ 154,299<\/td>\nU$ 153,686<\/td>\n<\/tr>\n
Custos de Aplica\u00e7\u00e3o<\/strong><\/td>\n<\/tr>\n
ANDA<\/td>\nU$ 196,868<\/td>\nU$ 225,712<\/td>\n<\/tr>\n
DMF Tipo II<\/td>\nU$ 69,921<\/td>\nU$ 74,952<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Taxas para Dispositivos M\u00e9dicos<\/strong><\/p>\n

A FDA requer o pagamento de taxas para determinadas aplica\u00e7\u00f5es de dispositivos m\u00e9dicos, relat\u00f3rios peri\u00f3dicos sobre dispositivos Classe III e para o registro anual de estabelecimentos. As empresas com vendas totais de menos de US $ 100 milh\u00f5es para o ano fiscal mais recente podem se qualificar como uma pequena empresa para acessar uma taxa reduzida nessas aplica\u00e7\u00f5es. As empresas com vendas totais com menos de US $ 30 milh\u00f5es podem receber uma isen\u00e7\u00e3o dos primeiros aplica\u00e7\u00f5es ou apresenta\u00e7\u00f5es 510k “Pr\u00e9 mercado”. Se voc\u00ea qualifica para uma taxa reduzida para o ano fiscal 2021, voc\u00ea deve enviar suas informa\u00e7\u00f5es novamente durante a renova\u00e7\u00e3o para a FDA a fim de manter a classifica\u00e7\u00e3o.<\/p>\n

Pequenas empresas n\u00e3o recebem uma redu\u00e7\u00e3o nas taxas de registros de estabelecimento. Os requisitos de registro de um estabelecimento s\u00e3o os mesmos para empresas de todos os tamanhos e a FDA n\u00e3o considera um registro a ser conclu\u00eddo at\u00e9, efetivamente, receber o pagamento. Al\u00e9m disso, esta taxa \u00e9 aplicada para cada um dos estabelecimentos que possui uma empresa e que possui certas fun\u00e7\u00f5es em dispositivos m\u00e9dicos. No ano 2022, as taxas de dispositivos m\u00e9dicos aumentaram aproximadamente 2,5% em compara\u00e7\u00e3o ao ano fiscal de 2021. A FDA explica que isso \u00e9 para cobrir o custo da infla\u00e7\u00e3o do ano passado.<\/p>\n

Taxas MDUFA para o Ano Fiscal 2022<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Tipo de Taxa<\/strong><\/td>\n2021<\/strong><\/td>\n2022<\/strong><\/td>\n<\/tr>\n
Registro Anual de Estabelecimento<\/td>\nU$ 5,546<\/td>\nU$ 5,672<\/td>\n<\/tr>\n
Custos de Aplica\u00e7\u00e3o<\/strong><\/td>\nPadr\u00e3o<\/strong><\/td>\nPequenos Neg\u00f3cios<\/strong><\/td>\nPadr\u00e3o<\/strong><\/td>\nPequenos Neg\u00f3cios<\/strong><\/td>\n<\/tr>\n
510(k)<\/td>\nU$ 12,432<\/td>\nU$ 3,108<\/td>\nU$ 12,745<\/td>\nU$ 3,186<\/td>\n<\/tr>\n
513(g)<\/td>\nU$ 4,936<\/td>\nU$ 2,468<\/td>\nU$ 5,061<\/td>\nU$ 2,530<\/td>\n<\/tr>\n
Classifica\u00e7\u00e3o De Novo<\/td>\nU$ 109,697<\/td>\nU$ 27,424<\/td>\nU$ 112,457<\/td>\nU$ 28,114<\/td>\n<\/tr>\n
PMA, PDP, PMR, BLA<\/td>\nU$ 365,657<\/td>\nU$ 91,414<\/td>\nU$ 374,858<\/td>\nU$ 93,714<\/td>\n<\/tr>\n
Suplementos Painel-track<\/td>\nU$ 274,243<\/td>\nU$ 68,561<\/td>\nU$ 281,143<\/td>\nU$ 70,286<\/td>\n<\/tr>\n
Suplementos 180-dias<\/td>\nU$ 54,849<\/td>\nU$ 13,712<\/td>\nU$ 56,229<\/td>\nU$ 14,057<\/td>\n<\/tr>\n
Suplementos em Tempo Real<\/td>\nU$ 25,596<\/td>\nU$ 6,399<\/td>\nU$ 26,240<\/td>\nU$ 6,560<\/td>\n<\/tr>\n
Suplementos de Efic\u00e1cia BLA<\/td>\nU$ 365,657<\/td>\nU$ 91,414<\/td>\nU$ 374,858<\/td>\nU$ 93,714<\/td>\n<\/tr>\n
Reporte Anual PMA<\/td>\nU$ 12,798<\/td>\nU$ 3,200<\/td>\nU$ 13,120<\/td>\nU$ 3,280<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A Registrar Corp \u00e9 uma empresa privada que auxilia as empresas em conformidade com os regulamentos com a FDA. Podemos ajud\u00e1-lo a determinar quais taxas se aplicam ao seu estabelecimento e facilitar o pagamento do FDA. Para mais informa\u00e7\u00f5es, ligue para + 1-757-224-0177, envie um e-mail para: info@registracorp.com<\/a> ou converse no chat com um consultor regulamentar 24 horas por dia em www.registricorcorp.com\/livechat<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos Estados Unidos (FDA) anunciou novas taxas para o ano fiscal (FY) 2022 sob a altera\u00e7\u00e3o das taxas de usu\u00e1rios para medicamentos gen\u00e9ricos (GDUFA) e a altera\u00e7\u00e3o da taxa de usu\u00e1rio para dispositivos m\u00e9dicos (MDFA). O ano fiscal come\u00e7a em 1\u00ba de outubro de 2021 e termina em 30<\/p>\n","protected":false},"author":30,"featured_media":39535,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","om_disable_all_campaigns":false,"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[99,96],"tags":[],"class_list":{"0":"post-51530","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medical-devices-pt","8":"category-drugs-pt","9":"entry"},"yoast_head":"\nA FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022 - Registrar<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022\" \/>\n<meta property=\"og:description\" content=\"A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos Estados Unidos (FDA) anunciou novas taxas para o ano fiscal (FY) 2022 sob a altera\u00e7\u00e3o das taxas de usu\u00e1rios para medicamentos gen\u00e9ricos (GDUFA) e a altera\u00e7\u00e3o da taxa de usu\u00e1rio para dispositivos m\u00e9dicos (MDFA). O ano fiscal come\u00e7a em 1\u00ba de outubro de 2021 e termina em 30\" \/>\n<meta property=\"og:url\" content=\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Registrar\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-05T14:13:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-19T13:50:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1650\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mason Grandusky\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mason Grandusky\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\"},\"author\":{\"name\":\"Mason Grandusky\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2\"},\"headline\":\"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022\",\"datePublished\":\"2021-08-05T14:13:22+00:00\",\"dateModified\":\"2021-08-19T13:50:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg\",\"articleSection\":[\"Medical Devices\",\"Medicamentos\"],\"inLanguage\":\"pt\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\",\"name\":\"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022 - Registrar\",\"isPartOf\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg\",\"datePublished\":\"2021-08-05T14:13:22+00:00\",\"dateModified\":\"2021-08-19T13:50:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#breadcrumb\"},\"inLanguage\":\"pt\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage\",\"url\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg\",\"contentUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg\",\"width\":1650,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/legacy.registrarcorp.com\/pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#website\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/\",\"name\":\"Registrar\",\"description\":\"Assistance with U.S. FDA Regulations\",\"publisher\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/legacy.registrarcorp.com\/pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#organization\",\"name\":\"Registrar Corp\",\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png\",\"contentUrl\":\"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png\",\"width\":1326,\"height\":330,\"caption\":\"Registrar Corp\"},\"image\":{\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2\",\"name\":\"Mason Grandusky\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt\",\"@id\":\"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g\",\"caption\":\"Mason Grandusky\"},\"url\":\"https:\/\/legacy.registrarcorp.com\/pt\/author\/mgrandusky\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022 - Registrar","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"pt_PT","og_type":"article","og_title":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022","og_description":"A Administra\u00e7\u00e3o de Alimentos e Medicamentos dos Estados Unidos (FDA) anunciou novas taxas para o ano fiscal (FY) 2022 sob a altera\u00e7\u00e3o das taxas de usu\u00e1rios para medicamentos gen\u00e9ricos (GDUFA) e a altera\u00e7\u00e3o da taxa de usu\u00e1rio para dispositivos m\u00e9dicos (MDFA). O ano fiscal come\u00e7a em 1\u00ba de outubro de 2021 e termina em 30","og_url":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/","og_site_name":"Registrar","article_published_time":"2021-08-05T14:13:22+00:00","article_modified_time":"2021-08-19T13:50:19+00:00","og_image":[{"width":1650,"height":500,"url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg","type":"image\/jpeg"}],"author":"Mason Grandusky","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mason Grandusky","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#article","isPartOf":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/"},"author":{"name":"Mason Grandusky","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2"},"headline":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022","datePublished":"2021-08-05T14:13:22+00:00","dateModified":"2021-08-19T13:50:19+00:00","mainEntityOfPage":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/"},"wordCount":798,"publisher":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg","articleSection":["Medical Devices","Medicamentos"],"inLanguage":"pt"},{"@type":"WebPage","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/","url":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/","name":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022 - Registrar","isPartOf":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg","datePublished":"2021-08-05T14:13:22+00:00","dateModified":"2021-08-19T13:50:19+00:00","breadcrumb":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#breadcrumb"},"inLanguage":"pt","potentialAction":[{"@type":"ReadAction","target":["https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/"]}]},{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#primaryimage","url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg","contentUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/08\/press_release.jpg","width":1650,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/legacy.registrarcorp.com\/pt\/fda-announces-new-medical-device-and-generic-drug-user-fees-for-fy-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/legacy.registrarcorp.com\/pt\/"},{"@type":"ListItem","position":2,"name":"A FDA anuncia novas taxas de usu\u00e1rios para Dispositivos M\u00e9dicos e Medicamentos Gen\u00e9ricos para o ano fiscal de 2022"}]},{"@type":"WebSite","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#website","url":"https:\/\/legacy.registrarcorp.com\/pt\/","name":"Registrar","description":"Assistance with U.S. FDA Regulations","publisher":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/legacy.registrarcorp.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt"},{"@type":"Organization","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#organization","name":"Registrar Corp","url":"https:\/\/legacy.registrarcorp.com\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/","url":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png","contentUrl":"https:\/\/legacy.registrarcorp.com\/wp-content\/uploads\/2019\/12\/regcorp_logo.png","width":1326,"height":330,"caption":"Registrar Corp"},"image":{"@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/5460f453ed04f326b4ef5280009675f2","name":"Mason Grandusky","image":{"@type":"ImageObject","inLanguage":"pt","@id":"https:\/\/legacy.registrarcorp.com\/pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/20ae894ac7fdae57b794f1b1792f9c9f1920bc809d0aab245d70e0aa7c997266?s=96&d=mm&r=g","caption":"Mason Grandusky"},"url":"https:\/\/legacy.registrarcorp.com\/pt\/author\/mgrandusky\/"}]}},"_links":{"self":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts\/51530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/comments?post=51530"}],"version-history":[{"count":0,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/posts\/51530\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/media\/39535"}],"wp:attachment":[{"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/media?parent=51530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/categories?post=51530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/legacy.registrarcorp.com\/pt\/wp-json\/wp\/v2\/tags?post=51530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}